Central Clinical Services

Help your sites work smarter and faster.

CCS removes operational burden from sites with flexible support, standardized processes, and proven execution that help trials run faster and more cost-effectively.

Hero Image

Reduce site administrative workload and lower costs.

Central Clinical Service (CCS) resources act as an extension of your site(s) team, operating under site PI oversight and in full alignment with site policies and the DOA. This shared model expands capacity across sites and trials.

Engage and qualify more study participants, faster.

CCS handles early participant interactions and screening activities on behalf of sites, ensuring every referral is followed up promptly and qualified efficiently.

Services include:

  • Contact, educate, and pre-screen potential participants
  • Review inclusion/exclusion criteria and medical histories
  • Obtain and organize medical records
  • Conduct remote consent (as approved per protocol)
  • Schedule and confirm pre-screening and screening visits
  • Communicate progress and status updates with site staff

Save 10%-20% on CTA spend relative to site completing these activities

Patient Management Services

Accelerating Enrollment of Research Studies

Building upon our proven innovations in clinical research operations and logistics, we designed and established the first IRB-approved pre-screening program to:

Feature 1

Sites leveraging CCS convert 20% more referrals into screening visits.

Feature 1

Sites leveraging CCS randomize 25% more participants.

Feature 2

Sites using CCS complete visits an average of six days faster, shortening overall trial timelines.

  • “[The Trial Lead] gave a lot of praise when the US announced that screening would be closing ~5-6 months early; [they] felt that a large part of this was because of the CCS support in the US.”

    - Sponsor on ph3 cardiovascular trial
  • “We appreciate this help that we are receiving to complete outstanding work and to recruit additional patients.”

    - Site on ph4 rheumatology trial

Contact Us